Prognostic factors in pediatric acute myeloid leukemia.
Acute myeloid leukemia (AML), a heterogeneous group of diseases with variable responses to the same therapy, comprises nearly a quarter of childhood acute leukemias. Although historically very few prognostic markers have been incorporated into therapeutic decision making in AML, recent advances in technology have enabled identification of numerous factors associated with disease outcome. This review provides a detailed analysis of most clinically relevant factors associated with disease outcome in childhood AML.
Radhi
Mohamed
M
Children's Mercy Hospital, Kansas City, MO 64108, USA. maradhi@cmh.edu
Meshinchi
Soheil
S
Gamis
Alan
A
D000367:Age Factors; D014408:Biomarkers, Tumor; D015992:Body Mass Index; D002648:Child; D003582:Cytogenetics; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D011110:Polymorphism, Genetic; D011379:Prognosis; D012307:Risk Factors; D012737:Sex Factors
D014408:Biomarkers, Tumor